Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

415 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study.
D'Angelo S, Cantini F, Ramonda R, Cantarini L, Carletto A, Chimenti MS, Delle Sedie A, Foti R, Gerli R, Lomater C, Lubrano E, Marchesoni A, Zabotti A, Salvarani C, Scrivo R, Scarpa R, Tramontano G, Nannini C, Lorenzin M, Fabbroni M, Martinis F, Perricone R, Carli L, Visalli E, Rovera G, Perrotta FM, Quartuccio L, Altobelli A, Costa L, Niccoli L, Ortolan A, Caso F. D'Angelo S, et al. Among authors: gerli r. Front Pharmacol. 2019 Dec 13;10:1497. doi: 10.3389/fphar.2019.01497. eCollection 2019. Front Pharmacol. 2019. PMID: 31920675 Free PMC article.
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.
Salvarani C, Macchioni P, Manzini C, Paolazzi G, Trotta A, Manganelli P, Cimmino M, Gerli R, Catanoso MG, Boiardi L, Cantini F, Klersy C, Hunder GG. Salvarani C, et al. Among authors: gerli r. Ann Intern Med. 2007 May 1;146(9):631-9. doi: 10.7326/0003-4819-146-9-200705010-00005. Ann Intern Med. 2007. PMID: 17470831 Clinical Trial.
Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors.
Iannone F, Gremese E, Atzeni F, Biasi D, Botsios C, Cipriani P, Ferri C, Foschi V, Galeazzi M, Gerli R, Giardina A, Marchesoni A, Salaffi F, Ziglioli T, Lapadula G; Gruppo Italiano di Studio sulle Early Arthritides (GISEA). Iannone F, et al. Among authors: gerli r. J Rheumatol. 2012 Jun;39(6):1179-84. doi: 10.3899/jrheum.111125. Epub 2012 Apr 1. J Rheumatol. 2012. PMID: 22467933
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry.
Atzeni F, Sarzi-Puttini P, Botsios C, Carletto A, Cipriani P, Favalli EG, Frati E, Foschi V, Gasparini S, Giardina A, Gremese E, Iannone F, Sebastiani M, Ziglioli T, Biasi D, Ferri C, Galeazzi M, Gerli R, Giacomelli R, Gorla R, Govoni M, Lapadula G, Marchesoni A, Salaffi F, Punzi L, Triolo G, Ferraccioli G. Atzeni F, et al. Among authors: gerli r. Autoimmun Rev. 2012 Dec;12(2):225-9. doi: 10.1016/j.autrev.2012.06.008. Epub 2012 Jul 13. Autoimmun Rev. 2012. PMID: 22796281
Quality of life and unmet needs in patients with inflammatory arthropathies: results from the multicentre, observational RAPSODIA study.
Giacomelli R, Gorla R, Trotta F, Tirri R, Grassi W, Bazzichi L, Galeazzi M, Matucci-Cerinic M, Scarpa R, Cantini F, Gerli R, Lapadula G, Sinigaglia L, Ferraccioli G, Olivieri I, Ruscitti P, Sarzi-Puttini P. Giacomelli R, et al. Among authors: gerli r. Rheumatology (Oxford). 2015 May;54(5):792-7. doi: 10.1093/rheumatology/keu398. Epub 2014 Oct 6. Rheumatology (Oxford). 2015. PMID: 25288786 Free article.
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry.
Iaccarino L, Bartoloni E, Carli L, Ceccarelli F, Conti F, De Vita S, Ferraccioli G, Galeazzi M, Gatto M, Gerli R, Govoni M, Gremese E, Iuliano A, Mansutti E, Moroni G, Mosca M, Nalli C, Naretto C, Padovan M, Palma L, Raffiotta F, Roccatello D, Tincani A, Valesini G, Zen M, Doria A. Iaccarino L, et al. Among authors: gerli r. Clin Exp Rheumatol. 2015 Jul-Aug;33(4):449-56. Epub 2015 Jun 8. Clin Exp Rheumatol. 2015. PMID: 26053285 Clinical Trial.
The Need to Target Mucosa-Associated Lymphoid Tissue for Preventing Lymphoma in Rheumatoid Factor-Positive Patients With Sjögren's Syndrome: Comment on the Article by Nocturne et al.
Quartuccio L, Baldini C, Bombardieri S, Priori R, Valesini G, Bartoloni E, Alunno A, Gerli R, Carubbi F, Giacomelli R, De Vita S. Quartuccio L, et al. Among authors: gerli r. Arthritis Rheumatol. 2016 May;68(5):1318-9. doi: 10.1002/art.39585. Arthritis Rheumatol. 2016. PMID: 26749397 No abstract available.
Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey.
Ramonda R, Marchesoni A, Carletto A, Bianchi G, Cutolo M, Ferraccioli G, Fusaro E, De Vita S, Galeazzi M, Gerli R, Matucci-Cerinic M, Minisola G, Montecucco C, Pellerito R, Salaffi F, Paolazzi G, Sarzi-Puttini P, Scarpa R, Bagnato G, Triolo G, Valesini G, Punzi L, Olivieri I; ATLANTIS study group. Ramonda R, et al. Among authors: gerli r. Arthritis Res Ther. 2016 Apr 1;18:78. doi: 10.1186/s13075-016-0977-2. Arthritis Res Ther. 2016. PMID: 27037139 Free PMC article.
Correlation between ESSDAI and ClinESSDAI in a real-life cohort of patients with Sjögren's syndrome.
Quartuccio L, Baldini C, Bartoloni E, Priori R, Carubbi F, Alunno A, Gandolfo S, Gattamelata A, Giacomelli R, Gerli R, Valesini G, Bombardieri S, De Vita S; GRISS Group (Gruppo di Ricerca Italiano sulla Sindrome di Sjögren). Quartuccio L, et al. Among authors: gerli r. Clin Exp Rheumatol. 2017 May-Jun;35(3):546-547. Epub 2017 Feb 10. Clin Exp Rheumatol. 2017. PMID: 28229815 No abstract available.
415 results